AqueSys brings in $7.5mm through its Series C round so far
AqueSys Inc. (implant to stop blindness due to glaucoma) has raised $7.5mm through its Series C venture round. According to the company's Form D, it may bring in another $27.5mm before closing.
- Medical Devices
- Implantable Devices
Surgical Equipment & Devices
- Minimally or Less Invasive
- Venture Financing
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.